human papillomavirus (virus like particle, 9-valent) vaccine

Trials studying human papillomavirus (virus like particle, 9-valent) vaccine

• phase4Immunogenicity of HPV Vaccine in Transplant Recipients.active not recruitingn=30
• phase4An Exploratory Open-Label Clinical Trial Evaluating the Immunogenicity of the 9-valent 2-dose HPV Vaccination Regimenactive not recruitingn=352
• —Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Departmentterminatedn=34
• phase2A Study on the Immune Response and Safety of an Adjuvanted Human Papillomavirus Vaccine When Given to Healthy Women 16 to 26 Years of Agecompletedn=1,080
• phase4Faster Elimination of HPV Infection and Cervical Cancer Using Concomitant HPV Vaccination and HPV Screening: A Demonstration Project in Rwandanot yet recruitingn=100,000